Cite
HARVARD Citation
Lewis-Wolfson, T. et al. (n.d.). 409: BARICITINIB VERSUS TOCILIZUMAB FOR THE TREATMENT OF MODERATE TO SEVERE COVID-19. Critical care medicine. p. 191. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Lewis-Wolfson, T. et al. (n.d.). 409: BARICITINIB VERSUS TOCILIZUMAB FOR THE TREATMENT OF MODERATE TO SEVERE COVID-19. Critical care medicine. p. 191. [Online].